Amazon Secures 200 MW Wind Power Deals in Sweden 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
MediaTek Shares Jump 10% on Nvidia’s $3.5 Billion Investment 
SpaceX Mobile Network Could Cost Up to $130 Billion, Bernstein Says 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
OpenAI Rejects Apple Trade Secret Theft Claims 
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
OpenAI Nears Astra AI Model Launch With Safety Focus 
Trump Secures Drug Pricing Deals With Nine Pharma Companies 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Add as a preferred source on Google
Reckitt Benckiser is considering the sale of its subsidiary, Mead Johnson Nutritionals, which is based in China. It was said that the British multinational consumer goods company is eyeing at least $2 billion for the deal.
Sources who have knowledge on the matter told Reuters that Reckitt Benckiser already hired the American financial services company, Morgan Stanley, to review its Mead Johnson infant formula unit in Greater China. The insiders were not names since the information shared is confidential.
The plans for the sale of Mead Johnson’s infant formula
Based on the report, Reckitt Benckiser could commence the sale process any time within the second quarter of this year. As soon as the bank receives feedback or recommendation from potential buyers, the sale will begin.
Then again, all the interested parties have been warned that Reckitt Benckiser has not made any definite decision yet, and business valuation could still change because of the negative effects of the COVID-19 pandemic. Moreover, in February, it was said that the company is exploring its other options on how to handle Mead Johnson’s infant formula unit.
In any case, Reckitt Benckiser acquired Mead Johnson in 2017 for $16.6 billion in 2017. The infant formula-maker gave the company billions from the sale of its leading milk brands that include Lactum, Enfapro, and Enfamil.
Why Mead Johnson is being sold
Reckitt Benckiser’s chief executive officer, Laxman Narasimhan, said that there is a big decline in sales in China which makes up 6 percent of the group sales. The reason for the dive is the closure of the Hong Kong border that is taking a long time to re-open due to coronavirus.
Also, the birth rate in one of the most populous countries in the world has gone down as well, so there is less infant to feed with the formula from Mead Johnson. Lastly, Chinese locals have been choosing to buy imported milk due to the 2008 milk contamination controversy scandal. In fact, it was noted that on China’s leading e-commerce platform, JD.Com, the top four best-selling brands of infant formula are all from foreign labels.
